Mission Bio Tapestri Genome Integrity CNV Solution

Mission Bio has launched the Tapestri Genome Integrity CNV Solution, a high-throughput single-cell platform to help cell and gene therapy developers and oncology researchers measure genome-wide copy number variants. The assay features automated reporting and multiplexing capabilities, and enables cell and gene therapy developers to uncover potentially adverse chromosomal events while simultaneously measuring genome editing outcomes. For oncology researchers, the solution enables the assessment of cell-to-cell aneuploidy and CNV events across the genome with the potential to co-measure SNVs and focal CNVs, Mission Bio said.